Peer-reviewedLicence not statedMultiple sclerosis (Houndmills, Basingstoke, England)27 Oct 2026

Multimodal Effects of CD40L Blockade in Multiple Sclerosis: Insights from Preclinical and Clinical Studies

Ismail Muwenda¹
Joshua S. Mytych¹
Ekdanai Uawithya¹
Megan Reidy¹
Meerah Khan¹
Yang Mao-Draayer¹

¹Multiple Sclerosis Center of Excellence, Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, 73104.

Repeated TRPA1 Blockade Reduces Nociception and Neuroinflammation in a Relapsing–Remitting Mouse Model of Multiple Sclerosis
Ana Clara Machado Luiz, Diulle Spat Peres, Sabrina Qader Kudsi +8
International Journal of Molecular Sciences27 Oct 2026Peer-reviewedCC BY 4.0PhysiologyCrossref
A 2-year multimodal prospective cohort study to predict sustained progression independent of relapse activity in multiple sclerosis
Luis Rafael Solís-Tarazona, Salma Reddam, Ana Merchán-Cabanillas +3
Frontiers in Neurology13 Oct 2026Peer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCPMC
Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
S. Leo, I. Dhoparee-Doomah, S. Negi +6
bioRxiv13 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immunocompetent, chemoresistant neuroblastoma preclinical models
Courtney Himsworth, Thomas Jackson, Chantelle Bowers +9
PLOS One27 Oct 2026Peer-reviewedCC BY 4.0Full textCell biology ImmunologyPLOSPMC
Case Report: Value of MR relaxometry and spectroscopy in multimodal imaging characterization of limbic encephalitis in systemic sclerosis
Florian Awin Stolz, Andrei Manzhurtsev, Marlene Bönstrup +5
Frontiers in radiology16 Oct 2026Peer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC

Cite

BibTeX

@article{muwenda2026multimodal,
  title = {{Multimodal Effects of CD40L Blockade in Multiple Sclerosis: Insights from Preclinical and Clinical Studies}},
  author = {Ismail Muwenda and Joshua S. Mytych and Ekdanai Uawithya and Megan Reidy and Meerah Khan and Yang Mao-Draayer},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  year = {2026},
  month = oct,
  doi = {10.1177/13524585261490852},
  url = {https://doi.org/10.1177/13524585261490852},
}

RIS

TY  - JOUR
TI  - Multimodal Effects of CD40L Blockade in Multiple Sclerosis: Insights from Preclinical and Clinical Studies
AU  - Ismail Muwenda
AU  - Joshua S. Mytych
AU  - Ekdanai Uawithya
AU  - Megan Reidy
AU  - Meerah Khan
AU  - Yang Mao-Draayer
PY  - 2026
DA  - 2026/10/27
JO  - Multiple sclerosis (Houndmills, Basingstoke, England)
DO  - 10.1177/13524585261490852
UR  - https://doi.org/10.1177/13524585261490852
SN  - 1352-4585
SN  - 1477-0970
ER  -

Related

Cite